ASHR vs XBI
Xtrackers Harvest CSI 300 China A-Shares ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.65% for ASHR.
- • ASHR pays a higher dividend yield (2.52%).
Side-by-side metrics
| Metric | ASHR | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.65% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.52% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $1.28B | $10.92B |
YTD return | -5.63% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.69 | 1.01 |
P/E ratio | 14.37 | — |
Last price | $30.80 | $156.41 |
Inception | — | — |
Issuer | Xtrackers | State Street |
ASHR top holdings
| 600519.SS | Kweichow Moutai Co Ltd Class A | 3.70% |
| 300308.SZ | Zhongji Innolight Co Ltd Class A | 2.83% |
| 300750.SZ | Contemporary Amperex Technology Co Ltd Class A | 2.65% |
| 601318.SS | Ping An Insurance (Group) Co. of China Ltd Class A | 2.47% |
| 600036.SS | China Merchants Bank Co Ltd Class A | 2.33% |
| 601899.SS | Zijin Mining Group Co Ltd Class A | 2.03% |
| 000333.SZ | Midea Group Co Ltd Class A | 1.91% |
| 600900.SS | China Yangtze Power Co Ltd Class A | 1.61% |
| 603259.SS | Wuxi AppTec Co Ltd Class A | 1.56% |
| 601166.SS | Industrial Bank Co Ltd Class A | 1.43% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About ASHR
ASHR (Xtrackers Harvest CSI 300 China A-Shares ETF) is China A-shares listed on Shanghai and Shenzhen exchanges. Managed by Xtrackers, the fund carries $1.3B in assets under management, an expense ratio of 0.65%, a dividend yield of 2.52%. Its largest holding is Kweichow Moutai Co Ltd Class A (600519.SS), which represents 3.7% of the portfolio. Real Estate is the fund's largest sector exposure at 0.5%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.